Equillium (EQ) Interest Coverage Ratio (2018 - 2026)
Equillium's (EQ) quarterly Interest Coverage Ratio came in at 0.53 in Q1 2026, up 99.43% year-on-year from 0.26 in Q1 2025, and up 99.48% on a QoQ basis from 101.59 in Q4 2025.
Equillium (EQ) Interest Coverage Ratio (2018 - 2026) Analysis & Trends
Equillium (EQ) has 9 years of Interest Coverage Ratio data on file, last reported at 0.53 in Q1 2026.
- On a quarterly basis, Interest Coverage Ratio rose 99.43% year-over-year to 0.53 in Q1 2026; TTM through Mar 2026 was 1.91, a 93.98% increase from a year earlier, with the FY2025 full-year figure at 0.43, down 166.12% from the prior year.
- Interest Coverage Ratio for Q1 2026 stood at 0.53, up from 101.59 in the prior quarter.
- Over the last five years, Interest Coverage Ratio for EQ reached as high as 7.54 in Q4 2022 and fell as low as 101.59 in Q4 2025.
- Historically, Interest Coverage Ratio has averaged 27.93 across 5 years, with a median of 17.71 in 2023.
- Across the five-year window, Interest Coverage Ratio soared 119.3% in 2022 and tumbled 44813.45% in 2025, its largest moves.
- Year by year, Interest Coverage Ratio stood at 7.54 in 2022, then plunged by 384.51% to 21.44 in 2023, then sank by 78.17% to 38.2 in 2024, then sank by 165.98% to 101.59 in 2025, then soared by 99.48% to 0.53 in 2026.
- Per Business Quant data, the three most recent Interest Coverage Ratio figures were 0.53 in Q1 2026, 101.59 in Q4 2025, and 1.04 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -157.58 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 7.60 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -0.38 |
| 10 | Equillium | 242.14 Mn | 242.14 Mn | - | -0.53 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.53 |
| Dec 31, 2025 | -101.59 |
| Sep 30, 2025 | -1.04 |
| Mar 31, 2025 | -92.40 |
| Dec 31, 2024 | -38.20 |
| Sep 30, 2024 | -1.21 |
| Jun 30, 2024 | -1.85 |
| Mar 31, 2024 | -0.21 |
| Sep 30, 2023 | -21.44 |
| Jun 30, 2023 | -3.13 |
| Mar 31, 2023 | -17.71 |
| Dec 31, 2022 | 7.54 |
| Sep 30, 2022 | -49.58 |
| Jun 30, 2022 | -47.38 |
| Mar 31, 2022 | -50.31 |
| Dec 31, 2021 | -39.05 |
| Sep 30, 2021 | -1.09 |
| Jun 30, 2021 | -1.50 |
| Mar 31, 2021 | -0.76 |
| Dec 31, 2020 | -32.50 |